Frontlight ResearchEarly access
CompletedNo phase
Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study
Key facts
- Who runs it
- Nanjing First Hospital, Nanjing Medical University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 7,227 people enrolled
- Started
- 1 Mar 2026
- Ended
- 25 Mar 2026
- Type of study
- Observational
- Treatments tested
- Antimicrobial susceptibility testing
- Record updated
- 9 April 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients who visited the Gastroenterology Department of Nanjing First Hospital and underwent gastroscopy with H. pylori culture and genetic testing between 2018 and 2024
- Positive for H. pylori by at least one diagnostic method (13C-urea breath test, rapid urease test, or histopathology)
- Provision of general written informed consent for the use of gastroscopy and specimen data in research
- Availability of complete medical records and laboratory test results
Who cannot take part
- Withdrawal of informed consent; use of antibiotics, proton pump inhibitors, H2-receptor antagonists, or bismuth agents within four weeks prior to gastroscopy
- History of gastric surgery
- Incomplete medical records or test results precluding evaluation
- Other factors deemed by the investigator to render the participant unsuitable for inclusion
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to provide an updated analysis of the resistance patterns of H. pylori in the Nanjing region, with a focus on characterizing the current status of phenotypic and genotypic resistance to these six antimicrobial agents. The findings are expected to offer a scientific basis for the rapid diagnosis and personalized treatment of H. pylori infection.
Treatments tested
- Antimicrobial susceptibility testing
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 9 April 2026